Workflow
Copper Road Announces Upsize to Financing
Globenewswire· 2025-12-17 12:00
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Copper Road Resources Inc. (TSX-V: CRD) ("Copper Road" or the "Company") announces today that it is amending certain terms of its non-brokered private placement previously announced on December 12, 2025. The amended Offering will consist of the sale of up to: (i) 8,500,000 common share units in the capital of the Company (each, a “Unit”) at a price of $0.035 per Unit ...
Why 2025 has been such a historic year for oil — with prices set to finish near a 5-year low
MarketWatch· 2025-12-17 12:00
The world has more oil than it needs, but a drop in crude prices this week to the lowest level in nearly five years may help slow production and boost demand. ...
Apple punted on AI this year. Next year will be critical
CNBC· 2025-12-17 12:00
In this articleAAPLTim Cook, CEO of Apple Inc., during the Apple Worldwide Developers Conference at Apple Park campus in Cupertino, California, on June 9, 2025.David Paul Morris | Bloomberg | Getty ImagesOne of the biggest launches in Apple's history is supposed to come next year, and it's got nothing to do with hardware. The company has promised investors that it will be launching the next generation of Siri, its artificial intelligence voice assistant. There's a lot riding on the launch of a "more persona ...
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
Globenewswire· 2025-12-17 12:00
NESS ZIONA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today provided an update following the unblinding of clinical data from its vehicle-controlled proof-of-concept Phase 1b study of SGT-210 on Darier disease. Following unblinding, the data from the vehicle-controlled Phase 1b proof-of-concept study did not show differentiation between SGT-210 and vehicle on the study’s ...
Germanium Mining Corp. Joins Nevada Mining Association
Thenewswire· 2025-12-17 12:00
Core Points - Germanium Mining Corp. has been accepted as a new member of the Nevada Mining Association, enhancing its commitment to responsible mining practices [1][3] - The membership provides access to industry networks, regulatory discussions, technical workshops, and best practices relevant to mining operations in Nevada [3] - The company has entered into loan agreements totaling CAD $100,000, with a loan fee of 15% and an interest rate of 10% per annum [4] Company Overview - Germanium Mining Corp. is a publicly traded mineral exploration company focused on discovery-stage mineral properties in top-tier mining jurisdictions across North America [4]
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
Globenewswire· 2025-12-17 12:00
Preliminary Phase 1b data is in line with Phase 1a data reported at the European Society of Medical Oncology in September 2025 Combined disease control rate of 90% across both Phase 1a and Phase 1b patients with confirmed partial and minor responses observed LONDON and PHILADELPHIA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced compelling new data in patients ...
Warner Bros. Discovery Board of Directors Unanimously Recommends Shareholders Reject Paramount Tender Offer
Prnewswire· 2025-12-17 12:00
Ellison Family Has Still Not Provided an Equity Backstop, Despite Headline Claims WBD Board's Full, Fair and Transparent Review Established a Level Playing Field in a Competitive Process Reiterates Recommendation in Support of Netflix Combination, Which Represents Superior, More Certain Value for Shareholders No Material Difference in Regulatory Risk Between PSKY Offer and Netflix Merger Paramount Offer Reflects Inadequate Value and Imposes Numerous, Significant Risks and Costs on WBD Illusory, Non-Binding ...
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 
Globenewswire· 2025-12-17 12:00
Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA, Minn., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a CDMO master services agreement with a new large global pharm ...
Predictmedix AI Inc - 2025 Year End Corporate Update
TMX Newsfile· 2025-12-17 12:00
Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company") concludes 2025 having delivered a year of disciplined execution across technology development, global investor engagement, and strategic advancement—positioning the Company for a pivotal growth phase in 2026 at the convergence of artificial intelligence, quantum-inspired computation, and digital healthcare.Throughout 2025, Predictmedix AI enhanced the per ...
Orestone Closes $2.24 Million Non-Brokered Private Placement Including Participation of Crescat Capital LLC
TMX Newsfile· 2025-12-17 12:00
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Orestone Mining Corp. (TSXV: ORS) (FSE: O2R2) ("Orestone" or the "Company") is pleased to announce the completion of its non-brokered private placement originally announced October 10, 2025 and updated October 14, 2025 and October 30, 2025. The Company issued 28,000,000 units ("Units") at a price of $0.08 per Unit for gross proceeds of $2,240,000. Each Unit consisted of one common share of the Company ("Common Share") and one common share ...